全文获取类型
收费全文 | 50388篇 |
免费 | 860篇 |
国内免费 | 501篇 |
专业分类
耳鼻咽喉 | 1083篇 |
儿科学 | 2402篇 |
妇产科学 | 1598篇 |
基础医学 | 2989篇 |
口腔科学 | 1815篇 |
临床医学 | 3054篇 |
内科学 | 7840篇 |
皮肤病学 | 896篇 |
神经病学 | 2807篇 |
特种医学 | 1499篇 |
外科学 | 14639篇 |
综合类 | 2950篇 |
一般理论 | 1篇 |
预防医学 | 2010篇 |
眼科学 | 1024篇 |
药学 | 2134篇 |
20篇 | |
中国医学 | 338篇 |
肿瘤学 | 2650篇 |
出版年
2023年 | 348篇 |
2022年 | 726篇 |
2021年 | 1231篇 |
2020年 | 686篇 |
2019年 | 6630篇 |
2018年 | 5147篇 |
2017年 | 2560篇 |
2016年 | 507篇 |
2015年 | 650篇 |
2014年 | 1526篇 |
2013年 | 1313篇 |
2012年 | 1253篇 |
2011年 | 1239篇 |
2010年 | 1062篇 |
2009年 | 986篇 |
2008年 | 910篇 |
2007年 | 899篇 |
2006年 | 714篇 |
2005年 | 604篇 |
2004年 | 549篇 |
2003年 | 564篇 |
2002年 | 455篇 |
2001年 | 451篇 |
2000年 | 386篇 |
1999年 | 366篇 |
1998年 | 288篇 |
1997年 | 214篇 |
1996年 | 160篇 |
1995年 | 163篇 |
1994年 | 128篇 |
1993年 | 82篇 |
1992年 | 67篇 |
1991年 | 56篇 |
1990年 | 57篇 |
1989年 | 60篇 |
1988年 | 62篇 |
1987年 | 56篇 |
1985年 | 1791篇 |
1984年 | 2426篇 |
1983年 | 1630篇 |
1982年 | 1901篇 |
1981年 | 1723篇 |
1980年 | 1587篇 |
1979年 | 1517篇 |
1978年 | 1294篇 |
1977年 | 896篇 |
1976年 | 1161篇 |
1975年 | 951篇 |
1974年 | 898篇 |
1973年 | 745篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
Qing-Yang Que Lin-Cheng Zhang Jia-Qi Bao Sun-Bin Ling Xiao Xu 《World journal of gastrointestinal surgery》2022,14(5):397-408
Over the last 40 years, the incidence and prevalence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have continued to increase. Compared to other epithelial neoplasms in the same organ, GEP-NENs exhibit indolent biological behavior, resulting in more chances to undergo surgery. However, the role of surgery in high-grade or advanced GEP-NENs is still controversial. Surgery is associated with survival improvement of well-differentiated high-grade GEP-NENs, whereas poorly differentiated GEP-NENs that may benefit from resection require careful selection based on Ki67 and other tissue bio markers. Additionally, surgery also plays an important role in locally advanced and metastatic disease. For locally advanced GEP-NENs, isolated major vascular involvement is no longer an absolute contraindication. In the setting of metastatic GEP-NENs, radical intended surgery is recommended for patients with low-grade and resectable metastases. For unresectable metastatic disease, a variety of surgical approaches, including cytoreduction of liver metastasis, liver transplantation, and surgery after neoadjuvant treatment, show survival benefits. Primary tumor resection in GEP-NENs with unresectable metastatic disease is associated with symptom control, prolonged survival, and improved sensitivity toward systemic therapies. Although there is no established neoadjuvant or adjuvant strategy, increasing attention has been given to this emerging research area. Some studies have reported that neoadjuvant therapy effectively reduces tumor burden, improves the effectiveness of subsequent surgery, and decreases surgical complications. 相似文献
6.
7.
8.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
9.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
10.
Omar Abdel-Rahman 《Clinical genitourinary cancer》2019,17(2):e329-e338